GlassScriptPhysician profile
Nathaniel Alabi
NPI 1609308592
$71,461.79
in general payments reported to CMS, 2019-2025
26 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,055 · 2021: $4,269 · 2022: $1,033 · 2023: $985 · 2024: $63K · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $62K · Food and Beverage: $3,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $61,896.00 |
| Food and Beverage | $3,209.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $55,296.00 | 2024 | |
| Skye Orthobiologics LLC | $6,600.00 | 2024 | |
| Paragon 28, INC. | $2,482.22 | 2021-2022 | |
| Smith+Nephew, INC. | $2,466.22 | 2020-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Stryker Corporation | $1,535.16 | 2020-2025 | Augment Injectable |
| Organogenesis INC. | $987.25 | 2022-2025 | Cygnus Dual, Affinity, Simplimax |
| Medtronic, INC. | $438.21 | 2021-2025 | Venaseal, Turbohawk, In.Pact Admiral |
| Linvatec Corporation | $257.85 | 2023 | Biobrace 23mm, Colink 2, Allograft Tissue |
| Medtronic Vascular, INC. | $205.92 | 2020 | |
| Acera Surgical, INC. | $191.15 | 2024 | Restrata Wound Matrix |
| Sanara Medtech INC. | $155.45 | 2021 | |
| Anika Therapeutics, INC. | $134.55 | 2022 | |
| Biosense Webster, INC. | $120.31 | 2022 | |
| Orthofix Medical, INC. | $116.84 | 2020 | |
| Kci USA, INC. | $90.55 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $88.02 | 2025 | |
| Treace Medical Concepts, INC. | $76.60 | 2023-2025 | |
| Angiodynamics, INC. | $39.42 | 2022 | |
| Kerecis Limited | $32.67 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acell, INC. | $32.63 | 2020 | |
| Innovation Technologies INC | $26.19 | 2025 | Irrisept |
| Boston Scientific Corporation | $24.07 | 2023 | Varithena Administration Pack |
| Pfizer INC. | $18.10 | 2022 | |
| Abbvie INC. | $17.17 | 2024 | |
| Amgen INC. | $15.79 | 2021 | |
| Tactile Systems Technology INC | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Alabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.